Company intelligence / Profile preview
Emplicure
Uppsala, Swedenemplicure.com ↗
- Ownership
- Private
- Employees
- ~15
- Development stage
- Other
01
Overview
Emplicure is a specialty pharmaceutical and consumer health company utilizing a bioceramic platform for drug delivery. Its lead pharmaceutical candidate, EMPLI03 (a tamper-resistant buprenorphine formulation for chronic pain), completed a Phase 1 study but failed to meet its pharmacokinetic target profile. The company subsequently shifted its primary commercial focus toward its Seratek nicotine delivery platform and launched several nicotine pouch brands (KLAR, TECTONIC, and småå) in Sweden and the UK. Emplicure was acquired and delisted from the Nasdaq First North Growth Market in 2023.
- Therapeutic areas
- PsychiatryNeurology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Emplicure.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Emplicure.